Home/Humanetics Corp./Colin G. Chinn, M.D., MHS, FACP
CG

Colin G. Chinn, M.D., MHS, FACP

Chief Medical Officer

Humanetics Corp.

Humanetics Corp. Pipeline

DrugIndicationPhase
BIO 300Non-Small Cell Lung Cancer (with radiotherapy)Phase 2